Interesting
Cochrane international reference reports only 2 Human studies that are relevant. Awaiting the peer reviewed paper on UK NHS Ashford and St Peter’s placebo study
- Forums
- ASX - By Stock
- SPL
- If Viraleze 7 day treatment is competing with Paxlovid - who wins
If Viraleze 7 day treatment is competing with Paxlovid - who wins, page-2
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
(20min delay)
|
|||||
Last
9.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.39M |
Open | High | Low | Value | Volume |
9.9¢ | 9.9¢ | 9.9¢ | $395 | 4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 142688 | 9.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
10.0¢ | 279845 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 142688 | 0.098 |
1 | 25885 | 0.096 |
2 | 1124859 | 0.095 |
3 | 172280 | 0.092 |
2 | 311111 | 0.090 |
Price($) | Vol. | No. |
---|---|---|
0.100 | 279845 | 8 |
0.105 | 265161 | 6 |
0.110 | 303882 | 7 |
0.115 | 110571 | 3 |
0.120 | 201197 | 5 |
Last trade - 10.40am 08/11/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online